Literature DB >> 25929575

Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.

Shuaizhang Li, Wen Zhang, Xuejiao Yin, Shilai Xing, Heidi Qunhui Xie, Zhengyu Cao, Bin Zhao1.   

Abstract

The ABC (ATP-binding cassette) transporter is one of the largest and most ancient protein families with members functioning from protozoa to human. The resistance of cancer and tumor cells to anticancer drugs is due to the over-expression of some ABC transporters, which may finally lead to chemotherapy failure. The mouse ABC transporters are classified into seven subfamilies by phylogenetic analysis. The mouse ABC transporter gene, alias, chromosomal location and function have been determined. Within the ABC super-family, the MDR transporters (Abcb1, Abcc1, Abcg2) in mouse models have been proved to be valuable to investigate the biochemistry and physiological functions. This review concentrates on the multidrug resistance of mouse ABC transporters in cancer and tumor cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25929575

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  7 in total

Review 1.  Human antigen R and drug resistance in tumors.

Authors:  Fenghai Zhou; Fa Zhang; Chuan Zhou; Mengtian Liang; Zhonglin Cai; Haidi Lv; Wenjuan Li; Xupan Wei
Journal:  Invest New Drugs       Date:  2019-01-05       Impact factor: 3.850

Review 2.  Long Noncoding RNAs: New Regulators of Resistance to Systemic Therapies for Gastric Cancer.

Authors:  Weihong Sun; Changqing Jiang; Ying Ji; Chao Xiao; Haiping Song
Journal:  Biomed Res Int       Date:  2021-01-06       Impact factor: 3.411

3.  Identification of Circ_001569 as a Potential Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer.

Authors:  Xianbo Shen; Yun Chen; Jibin Li; Huaiyin Huang; Chuping Liu; Ning Zhou
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

4.  Mutant p53 promotes RCP-dependent chemoresistance coinciding with increased delivery of P-glycoprotein to the plasma membrane.

Authors:  Vinaya Phatak; Yannick von Grabowiecki; Justyna Janus; Leah Officer; Caron Behan; Lydia Aschauer; Lucia Pinon; Hannah Mackay; Sara Zanivan; Jim C Norman; Michael Kelly; John Le Quesne; Patricia A J Muller
Journal:  Cell Death Dis       Date:  2021-02-24       Impact factor: 8.469

Review 5.  PARP inhibitor resistance in breast and gynecological cancer: Resistance mechanisms and combination therapy strategies.

Authors:  Nannan Wang; Yan Yang; Dongdong Jin; Zhenan Zhang; Ke Shen; Jing Yang; Huanhuan Chen; Xinyue Zhao; Li Yang; Huaiwu Lu
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

6.  Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals.

Authors:  Pengjun Zhou; Rong Zhang; Ying Wang; Dandan Xu; Li Zhang; Jinhong Qin; Guifeng Su; Yue Feng; Hongce Chen; Siyuan You; Wen Rui; Huizhong Liu; Suhong Chen; Hongyuan Chen; Yifei Wang
Journal:  Oncotarget       Date:  2017-11-27

7.  Involvement of DNA methyltransferase 1 (DNMT1) and multidrug resistance-associated proteins in 2-methoxyestradiol-induced cytotoxicity in EC109/Taxol cells.

Authors:  Qingqing Yang; Xiaojing Guo; Yue Xu; Chang Duan; Haofan Wang; Quanling Feng; Nan Zhang
Journal:  Transl Cancer Res       Date:  2021-01       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.